Mark J. Vignola

Insider Reports History

Location
New York, NY
Signature
/s/ David Strauss, as Attorney-in-Fact for Mark J. Vignola
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark J. Vignola:

Company Role Class Num Shares Value Price $ Report Date Ownership
Terns Pharmaceuticals, Inc. Chief Financial Officer Common Stock 74,752 $433,210 $5.80 06 Jan 2025 Direct
Terns Pharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 55,000 10 Sep 2024 Direct

Insider Reports Filed by Mark J. Vignola

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TERN Terns Pharmaceuticals, Inc. 02 Jan 2025 2 -$99,024 4 Chief Financial Officer 06 Jan 2025, 19:30
TERN Terns Pharmaceuticals, Inc. 10 Sep 2024 3 -$56,400 4 Chief Financial Officer 12 Sep 2024, 18:10
TERN Terns Pharmaceuticals, Inc. 31 May 2024 1 +$21,272 4 Chief Financial Officer 04 Jun 2024, 18:05
TERN Terns Pharmaceuticals, Inc. 23 Jan 2024 2 $0 4 Chief Financial Officer 25 Jan 2024, 19:17
TERN Terns Pharmaceuticals, Inc. 30 Nov 2023 1 +$2,809 4 Chief Financial Officer 04 Dec 2023, 18:03
TERN Terns Pharmaceuticals, Inc. 31 May 2023 1 +$14,096 4 Chief Financial Officer 02 Jun 2023, 17:03
TERN Terns Pharmaceuticals, Inc. 01 Feb 2023 2 +$4.23 4 Chief Financial Officer 03 Feb 2023, 17:01
TERN Terns Pharmaceuticals, Inc. 31 May 2022 1 +$11,254 4 Chief Financial Officer 08 Jun 2022, 21:27
TERN Terns Pharmaceuticals, Inc. 26 Jan 2022 1 $0 4 Chief Financial Officer 28 Jan 2022, 20:02
TERN Terns Pharmaceuticals, Inc. 28 Sep 2021 1 $0 4 Chief Financial Officer 30 Sep 2021, 21:17